Figure 5
Figure 5. Comparison between monocyte subset profile and monocyte count diagnosis. (A) ROC curves of the “MO1 percentage >94.0%” and “monocyte count >1 × 109/L” criteria to identify CMML at initial workup in the validation cohort. The difference between the 2 curves was highly significant (P < .0001, χ2 test). (B) Monocyte subset repartition analyzed in 2 independent samples obtained from 3 patients classified as having MDS and showing a fluctuating monocyte count of ∼1 × 109/L that precludes their classification as CMML according to the WHO criteria. (C) Monocyte subset repartition analyzed in 2 independent samples obtained from a patient who could be classified as having CMML according to the WHO criteria but who, based on cytologic and molecular analyses, demonstrates sideroblastic anemia with monocytosis.

Comparison between monocyte subset profile and monocyte count diagnosis. (A) ROC curves of the “MO1 percentage >94.0%” and “monocyte count >1 × 109/L” criteria to identify CMML at initial workup in the validation cohort. The difference between the 2 curves was highly significant (P < .0001, χ2 test). (B) Monocyte subset repartition analyzed in 2 independent samples obtained from 3 patients classified as having MDS and showing a fluctuating monocyte count of ∼1 × 109/L that precludes their classification as CMML according to the WHO criteria. (C) Monocyte subset repartition analyzed in 2 independent samples obtained from a patient who could be classified as having CMML according to the WHO criteria but who, based on cytologic and molecular analyses, demonstrates sideroblastic anemia with monocytosis.

Close Modal

or Create an Account

Close Modal
Close Modal